Navigation Links
joimax(R) Revolutionizes Spine Surgery With the Launch of Newest and Fully-Endoscopic Product Innovations to Treat Spinal Canal Stenosis
Date:6/3/2008

KARLSRUHE, Germany, June 3 /PRNewswire/ -- The joimax(R) company in Karlsruhe, Germany, is the first company in the medical industry which developed a unique instrumentation for the treatment of spinal canal stenosis. Having this degenerative disease at the spinal column, bony excrescences (osteophytes) narrow the spinal canal and drastically limit the motoric and sensoric function of the affected person. The so called 360 degree TESSYS(TM) Spinal Stenosis System, which has been realized in cooperation with Dr. Rudolf Morgenstern, Barcelona, Spain (Centro Medico de Terapia de la Columna), enables surgeons to completely remove this osseous/bony material under direct endoscopic view through the vertebral foramen. Especially relating to elderly people in industrialised countries, spinal canal stenosis is a frequent growing disease of the spine. So far, affected patients are operated, if possible, with the open microsurgical method under full anaesthesia - however, this causes bigger tissue damage and may result in instability of the spinal column. "With our new method the patient is under local anaesthetics and via a fingernail-like cut the minimal access to the stenosis is enabled. Surrounding tissue is hardly damaged and thanks to new endoscopic reamers and chisels allowing removal of osteophytes, treated patients can leave the hospital only a few hours after the surgery", explains Dr. Rudolf Morgenstern.

A further product innovation revolutionizing spinal surgery is the so called iLESSYS(TM) - interLaminar Endoscopic Surgical System. It enables the fully dorsal endoscopic access to the lamina and to the spinal canal, which in a stenotic patient situation is heavily compressing all structures. "With iLESSYS(TM) and together with the TESSYS(TM) Stenosis System a full 360 degree spinal canal treatment offering is now made available for tissue, but if indicated, also for bony decompression procedures," summarizes Wolfgang Ries, founder and CEO of the joimax(R) GmbH.

Both new instrumentations are based on the TESSYS(TM) - Transforaminal Endoscopic Surgical System, an operation technique and method which is used worldwide for the removal of lumbar disc herniations. Surgeons are regularly offered the opportunity to familiarize themselves with this sophisticated platform technology by using the instruments in hands-on sessions, and at the same time exchange experiences with their peers. For example, during the Spineweek, Geneva, Switzerland, May 27th - 31st 2008, at which joimax(R) had organized a lunch symposium and showed good presence at the industrial exhibition. Further events with joimax(R) are:

DGNC - 59th Annual Conference of the German Society for Neurosurgery, held June, 1st - 4th 2008 in Wurzburg, Germany: joimax(R) is represented with a booth exhibition and is again organising a Lunch-Symposium for TESSYS(TM).

Additionally at The 1st WCMISST - World Congress of Minimally Invasive Spine Surgery & Techniques, June, 3rd -7th 2008 in Honolulu, Hawaii: Here joimax(R) offers Cadaver Workshops on June 3rd and 4th, besides presenting its latest new products at the industrial exhibition.

Another next innovation of the joimax(R) product portfolio is the Video TWISTER, a unique electronic device enabling a 360 degree video rotation continuously adjustable. Additionally, a zoom in magnification and an image centring function are made available.

About joimax(R): The young medical devices company is focusing on combined minimal access technologies ("joined minimal access technologies"), especially for spinal treatment. As a unique player, joimax(R) develops, manufactures and markets highly sophisticated and user friendly platform systems for endoscopic spinal surgery, which are evolving by experience and which are well evaluated to succeed. Due to education and multi-year business experience of its employees, joimax(R) has gained core competencies in medical devices, systems, hard- and software, instruments, endoscopes, disposables, implants and even radiation protection. It also offers a well thought-out Education Program that comprises three steps: Firstly attending a workshop, then a visitation at one of the reference centres, and finally conducting first own surgeries together with experienced application specialists. With this, the best possible training is being guaranteed.

joimax(R) sees itself as a partner for the treating medical doctor with the aim: help treating patients!
Further information please find on: http://www.joimax.com

Contact :

joimax GmbH

Adriana Oldiges

Marketing Communication Manager

An der RaumFabrik 33a

Amalienbadstrasse 36

76227 Karlsruhe

Phone: +49-721-255-14-314

Fax: +49-721-255-14-920

Mail: adriana.oldiges@joimax.com

Net: http://www.joimax.com


'/>"/>
SOURCE joimax GmbH
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SecureWorks Revolutionizes Security Information Management With New, On-Demand Service
2. Medical Imaging Revolutionizes Modern Medicine
3. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
4. Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
5. Atlas Spine Launches Stature(TM) Vertebral Body Replacement System
6. C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland
7. The Future of Spine Care Has Just Gotten Better With the Use of SpineSix BioMotion Spinal System(TM)
8. Atlas Spine Releases Back-PAK(TM) Discectomy Set
9. Zero Patient Infections Reported as D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals
10. Life Spine Expands Home Office Space, More Than Doubling Space Occupied
11. Life Spine Adds New Lynx(TM) Cross Connector to Its Lumbar Fixation Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: